A Randomized Study to Assess the Potential for Phototoxicity of SPF 50 Y65 110, SPF 50 Y51 002 and SPF 15 V27-104 in Human Subjects
Overview
- Phase
- Not Applicable
- Intervention
- SPF 50 Y65 110 (BAY987519)
- Conditions
- Sunscreen Agents
- Sponsor
- Bayer
- Enrollment
- 32
- Primary Endpoint
- Skin irritation
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride [NaCl]) after a single 24 h application of test materials followed by irradiation with ultraviolet A (UVA) and ultraviolet B (UVB).
The secondary objective of this study was to evaluate the safety of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with UVA/B irradiation by monitoring adverse events (AEs) throughout the study.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female subjects, aged 18 to 65 years
- •Good general health, as assessed by medical history and brief visual examination of the skin
- •Fitzpatrick skin Type I IV, determined by interview at screening
- •Willing and able to practice an acceptable measure of contraception during the study, if female of childbearing potential
- •Willing to follow study rules, which include: no sun exposure; avoidance of activities that would cause excessive sweating; and no use of lotions, creams, or oils on the back area
- •Must be willing not to change current brand of personal care products such as soaps, body washes, laundry detergent, body sprays, and body spritzes while participating in the study
Exclusion Criteria
- Not provided
Arms & Interventions
SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104
All test products (SPF 50 Y65 110,SPF 50 Y51 002, and SPF 15 V27 l 04 compared to that of a negative control \[0.9% NaCl\]) were tested simultaneously on each subject.
Intervention: SPF 50 Y65 110 (BAY987519)
SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104
All test products (SPF 50 Y65 110,SPF 50 Y51 002, and SPF 15 V27 l 04 compared to that of a negative control \[0.9% NaCl\]) were tested simultaneously on each subject.
Intervention: SPF 50 Y51 002 (BAY987519)
SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104
All test products (SPF 50 Y65 110,SPF 50 Y51 002, and SPF 15 V27 l 04 compared to that of a negative control \[0.9% NaCl\]) were tested simultaneously on each subject.
Intervention: SPF 15 V27 104 (BAY987519)
SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104
All test products (SPF 50 Y65 110,SPF 50 Y51 002, and SPF 15 V27 l 04 compared to that of a negative control \[0.9% NaCl\]) were tested simultaneously on each subject.
Intervention: Sodium chloride [NaCl]
Outcomes
Primary Outcomes
Skin irritation
Time Frame: up to 1 week
Skin irritation was rated on a scale from 0-7 where 0 is no evidence of irritation and 7 is strong reaction spreading beyond test site
Secondary Outcomes
- Number of adverse event as a measure of safety and tolerability(up to 1 week)